Drug intelligence / Profile preview

fluazuron

Development stage
Unknown
Lead developer
Novartis
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical, Oral
01

Overview

Fluazuron is a benzoylphenylurea compound and an insect growth regulator used primarily in veterinary medicine for the control of cattle ticks, especially Rhipicephalus (Boophilus) microplus. It acts as a chitin synthesis inhibitor, interfering with the formation and deposition of chitin in ticks during engorgement, molting, and hatching. This disrupts the development of tick larvae and nymphs, preventing successful molting and leading to death during these stages. Adult female ticks exposed to fluazuron may lay eggs that fail to hatch due to impaired chitin synthesis in developing embryos[1][3][5][6]. Fluazuron is administered topically as a pour-on formulation for beef cattle at doses typically ranging from 1.5 to 2.5 mg/kg body weight[1][3]. The drug has a systemic mode of action; after absorption through the skin or ingestion by licking, it distributes throughout the animal's body fat and is slowly released back into circulation over several months[6]. Its use is mainly preventative or for population control rather than rapid elimination of existing heavy infestations[6].

Brand names
Acatak
Other names
Fluazuronum
02

Targets

Chitin Synthase (Insect)

Beyond the preview

Go deeper on fluazuron.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluazuron.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call